Movement Alert｜Baoji Pharma-B Falls 5.46% in Regular Trading, MSCI Inclusion Takes Effect Amid Broad Biotech Sector Weakness

Market Focus06-01

On June 1, Baoji Pharma-B declined 5.46% in regular trading, trading at 23.06 HKD/share, with trading volume of approximately 43.34 million HKD. The stock continued to face selling pressure as the first trading day following its formal inclusion in the MSCI Global Index, which took effect after the May 29 close.

The broader biotechnology sector experienced systemic weakness on the same day, with BEIGENE down 3.56%, Innovent Bio down 3.0%, and SKB Bio down 7.1%, amplifying downward pressure on individual names. MSCI index inclusion events often trigger short-term sell-the-news dynamics as passive rebalancing flows complete.

Baoji Pharma-B has been trading at depressed levels since a 65% flash crash in late April that wiped approximately 58.5 billion HKD from its market capitalization. Despite recent positive developments — including the appointment of Dr. Liu Yanjun as new board chairman, a first-time Buy rating from Zhongyou Securities, and the controlling shareholder signaling intent to increase holdings — market confidence remains in an early-stage recovery phase.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1133914789?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-01 14:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1133914789","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Baoji Pharma-B Falls 5.46% in Regular Trading, MSCI Inclusion Takes Effect Amid Broad Biotech Sector Weakness","media":"Market Focus","content":"<p><p>On June 1, Baoji Pharma-B declined 5.46% in regular trading, trading at 23.06 HKD/share, with trading volume of approximately 43.34 million HKD. The stock continued to face selling pressure as the first trading day following its formal inclusion in the MSCI Global Index, which took effect after the May 29 close.</p><p>The broader biotechnology sector experienced systemic weakness on the same day, with BEIGENE down 3.56%, Innovent Bio down 3.0%, and SKB Bio down 7.1%, amplifying downward pressure on individual names. MSCI index inclusion events often trigger short-term sell-the-news dynamics as passive rebalancing flows complete.</p><p>Baoji Pharma-B has been trading at depressed levels since a 65% flash crash in late April that wiped approximately 58.5 billion HKD from its market capitalization. Despite recent positive developments — including the appointment of Dr. Liu Yanjun as new board chairman, a first-time Buy rating from Zhongyou Securities, and the controlling shareholder signaling intent to increase holdings — market confidence remains in an early-stage recovery phase.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Baoji Pharma-B Falls 5.46% in Regular Trading, MSCI Inclusion Takes Effect Amid Broad Biotech Sector Weakness</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Baoji Pharma-B Falls 5.46% in Regular Trading, MSCI Inclusion Takes Effect Amid Broad Biotech Sector Weakness\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-01 14:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 1, Baoji Pharma-B declined 5.46% in regular trading, trading at 23.06 HKD/share, with trading volume of approximately 43.34 million HKD. The stock continued to face selling pressure as the first trading day following its formal inclusion in the MSCI Global Index, which took effect after the May 29 close.</p><p>The broader biotechnology sector experienced systemic weakness on the same day, with BEIGENE down 3.56%, Innovent Bio down 3.0%, and SKB Bio down 7.1%, amplifying downward pressure on individual names. MSCI index inclusion events often trigger short-term sell-the-news dynamics as passive rebalancing flows complete.</p><p>Baoji Pharma-B has been trading at depressed levels since a 65% flash crash in late April that wiped approximately 58.5 billion HKD from its market capitalization. Despite recent positive developments — including the appointment of Dr. Liu Yanjun as new board chairman, a first-time Buy rating from Zhongyou Securities, and the controlling shareholder signaling intent to increase holdings — market confidence remains in an early-stage recovery phase.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02659","symbol_name":"宝济药业-B","start_time":0,"source_url":"","article_id":"1133914789","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1133914789","pubTimestamp":1780295824,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 1, Baoji Pharma-B declined 5.46% in regular trading, trading at 23.06 HKD/share, with trading volume of approximately 43.34 million HKD. The stock continued to face selling pressure as the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02659":"宝济药业-B"},"translate_title":"动向提示|宝鸡医药-B常规交易跌5.46%生物科技板块普遍疲软下纳入MSCI生效","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02659":1},"content_text":"On June 1, Baoji Pharma-B declined 5.46% in regular trading, trading at 23.06 HKD/share, with trading volume of approximately 43.34 million HKD. The stock continued to face selling pressure as the first trading day following its formal inclusion in the MSCI Global Index, which took effect after the May 29 close.The broader biotechnology sector experienced systemic weakness on the same day, with BEIGENE down 3.56%, Innovent Bio down 3.0%, and SKB Bio down 7.1%, amplifying downward pressure on individual names. MSCI index inclusion events often trigger short-term sell-the-news dynamics as passive rebalancing flows complete.Baoji Pharma-B has been trading at depressed levels since a 65% flash crash in late April that wiped approximately 58.5 billion HKD from its market capitalization. Despite recent positive developments — including the appointment of Dr. Liu Yanjun as new board chairman, a first-time Buy rating from Zhongyou Securities, and the controlling shareholder signaling intent to increase holdings — market confidence remains in an early-stage recovery phase.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1133914789","isCrawlerRequest":true}